During ESMO 2023, oncologists came together to discuss lung cancer data emerging from the congress and the potential implications for clinical practice in the US, Japan and China. The meeting co-hosts each shared their views on key data from three abstracts presented during ESMO before opening up the discussion to the panel. Watch the on-demand video to hear what they had to say.

 

Panel

  • Prof. Li Zhang, Sun Yat-sen University Cancer Center, Guangzhou, China

  • Prof. Tetsuya Mitsudomi, Kindai University, Osaka, Japan

  • Prof. Pasi A. Jänne, Dana-Farber Cancer Institute, Boston (MA), USA

  • Prof. Xiuning Le, MD Anderson Cancer Center, Houston (TX), USA

 

Clinical Takeaways

  • Updated results show that BL-B01D1 has potential in treating NSCLC patients who progressed after standard therapies.
  • In the KEYNOTE-671, perioperative pembrolizumab regimen significantly improves overall survival in resectable NSCLC versus placebo.
  • In the FLAURA2 trial, combining platinum-pemetrexed with osimertinib improves PFS in EGFR-mutated advanced NSCLC patients as compared to osimertinib alone, with a manageable safety profile.

 

Trials

  • BL-B01D1 bispecific EGFRxHER3 antibody drug conjugate trial
  • KEYNOTE-671
  • APG-1252 with Osimertinib for EGFR-mutant NSCLC
  • FLAURA2
  • RAMOSE
  • MARIPOSA
  • Inform oncologists about the latest clinical insights in lung oncology presented during EMSO 2023
  • Understand the impact of the latest clinical insights on clinical practice in the US, Japan and China
Programme summary
  • clock Duration 43 MIN
  • clock Language(s) flag
Watch the video now
Share this programme
This educational programme is supported by an Independent Educational Grant from SystImmune and BeiGene Europe.
Supporter Acknowledgement
This educational programme is supported by an Independent Educational Grant from SystImmune and BeiGene Europe.
I agree that this educational programme:

Was valuable to me

1/4

Other programmes of interest

symposium Symposium
Oncology 
ER+/HER2- metastatic breast cancer: Highlights from ESMO Breast Cancer 2025 Satellite Symposium

Medical experts discuss treatment strategies and sequencing after ET + CDK4/6i for ER+/HER2- metastatic breast cancer

Experts
Prof. Wolfgang Janni, Prof. Sherko Kümmel, Prof. Michail Ignatiadis
  • download Downloadable
    Resources
  • clock 5 MIN
  • calendar May 2025

This programme has been sponsored by Menarini Stemline and is intended for healthcare professionals only
podcast Podcast
Hemostasis and bleeding disorders Oncology 
Serie de podcasturi referitoare la gestionarea trombozei

Experți de renume din domeniul medical își împărtășesc perspectivele. Navigați în secțiuni pentru a selecta un episod al podcastului 

Experts
Prof. Dimitrios Tsakiris, Dr Lars Asmis, Prof. Jerzy Windyga, Prof. Daniel Bolliger
  • download Downloadable
    Resources
  • clock 21 MIN
  • calendar May 2025

This educational programme is supported by an Independent Educational Grant from Viatris.
video Video
Oncology Hemato-oncology 
Optimising the sequence of novel therapies from early relapse in multiple myeloma

Improving the survival of patients with relapsed/refractory multiple myeloma

Experts
Prof. Hermann Einsele, Prof. Evangelos Terpos
  • download Downloadable
    Resources
  • clock 2 MIN
  • calendar May 2025

This programme has been sponsored by Menarini Stemline and is intended for healthcare professionals only
animated-video Animated Video
Oncology 
BRAF V600E mutated NSCLC: The evolving treatment landscape

Expert insights into personalised treatment strategies in BRAF-mutated NSCLC

Experts
Prof. Amanda Tufman
Endorsed by
BRAF Bombers ICAN international cancer advocacy network Biomarker Collaborative
Lung Cancer Europe
  • download Downloadable
    Resources
  • clock 6 MIN
  • calendar May 2025

This content is intended for HCPs outside the UK & ROI only. The medical experts in this podcast are expressing their own views and not those of COR2ED, Supporters or their institution. This programme is supported by an Independent Educational Grant from Pierre Fabre Laboratories.  The programme is, therefore, independent; the content is not influenced by Pierre Fabre Laboratories and is under the sole responsibility of the experts. 
podcast Podcast
Oncology 
Tackling metastatic pancreatic ductal adenocarcinoma (mPDAC)

Chemotherapy strategies that matter

Experts
Prof. Shubham Pant, Prof. Efrat Dotan
Endorsed by
DiCE ICAN international cancer advocacy network
  • download Downloadable
    Resources
  • clock 4 MIN
  • calendar May 2025

Educational programme supported by an Independent Educational Grant from Ipsen USA
podcast Podcast
Oncology 
Understanding rare non-small cell lung cancer (NSCLC) alterations

Insights and support for patients

Experts
Dr Joshua Sabari, Debra Montague
  • download Downloadable
    Resources
  • clock 4 MIN
  • calendar May 2025

Educational programme supported by an Independent Educational Grant from Boehringer Ingelheim